Nano Dimension (NNDM) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Achieved record Q2 2024 revenue of $15.0M, up 2% year-over-year, despite macroeconomic headwinds, especially in central Europe.
Gross margins reached 45.4% in Q2 2024, with adjusted gross margins up year-over-year for the half-year period.
Net cash burn reduced by 69% year-over-year for H1 2024, reaching $11M in Q2 2024, reflecting successful expense reduction initiatives.
Announced definitive agreement to acquire Desktop Metal for up to $183M in cash, expected to close by year-end pending regulatory and shareholder approvals.
Strategic focus on integrating acquisitions, expanding into Industry 4.0, and emphasizing software and AI-driven solutions.
Financial highlights
Q2 2024 revenue: $15.0M (Q2 2023: $14.7M); H1 2024 revenue: $28.4M (H1 2023: $29.7M).
Q2 2024 gross margin: 45.4%; adjusted gross margin: 46.6%.
Q2 2024 net cash burn: $11M, down from $31M in Q2 2023.
Q2 2024 adjusted EBITDA loss: $16.1M (Q2 2023: $23.5M loss).
Total assets at $911M and total equity at $870M as of Q2 2024.
Outlook and guidance
Management expects the Desktop Metal acquisition to transform scale and business model, with a pro forma 2023 revenue of $246M and 28% recurring revenue.
Focus remains on operational excellence, synergy realization, and driving toward positive EBITDA and cash generation post-acquisition.
Targeting positive cash flow and profitability, with 64% progress toward this goal.
Acquisition of Desktop Metal expected to close in Q4 2024, subject to regulatory and shareholder approvals.
Expecting continued growth in digital Industry 4.0 and additive manufacturing, especially in metal segments.
Latest events from Nano Dimension
- Shareholders face a pivotal vote on Board control, with future input on strategic transactions.NNDM
Proxy filing10 Jul 2026 - Q3 revenue surged 81% to $26.9M, but margins fell; Q4 guidance: $31.5M–$33.5M.NNDM
Q3 20259 Jul 2026 - Proxy contest seeks board overhaul, annual elections, and more shareholder control over key decisions.NNDM
Proxy filing30 Jun 2026 - Shareholders will vote on strategic direction, governance amendments, and board composition changes.NNDM
Proxy filing29 Jun 2026 - Board supports strategic review and declassification, opposes governance and director changes.NNDM
Proxy filing25 Jun 2026 - Proxy contest aims to declassify the board, restrict poison pills, and replace key directors.NNDM
Proxy filing18 Jun 2026 - Proposed merger with Infinite Epigenetics offers a 20% premium and pivots to AI-powered diagnostics.NNDM
Proxy filing17 Jun 2026 - $890M merger forms a Nasdaq-listed AI diagnostics leader targeting the $90–94B U.S. market.NNDM
M&A announcement16 Jun 2026 - Nano and Infinite plan a merger to create an AI-powered health diagnostics company, pending approvals.NNDM
Proxy filing15 Jun 2026